Boston Scientific (BSX) PT Raised to $64 at Canaccord Genuity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $43.50 --0%
Rating Summary:
28 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
28 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Canaccord Genuity analyst William Plovanic raised the price target on Boston Scientific (NYSE: BSX) to $64.00 (from $60.00) while maintaining a Buy rating.
You May Also Be Interested In
- Increasing unusual call option volume: BSX SGHC USAS SYF INO CHGG EVGO REAL ITB MNRO KMX MSOS SGI PGY HNST GMAB
- Ventive Hospitality (VENTIVE:IN) PT Lowered to INR638 at Axis Capital Limited
- Boston Scientific (BSX) PT Lowered to $45 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
